145 related articles for article (PubMed ID: 2533039)
1. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation.
Howey JE; Bennet WM; Browning MC; Jung RT; Fraser CG
Diabet Med; 1989 Dec; 6(9):793-6. PubMed ID: 2533039
[TBL] [Abstract][Full Text] [Related]
2. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
[TBL] [Abstract][Full Text] [Related]
3. A comparison of fructosamine and glycosylated haemoglobin measurements at a diabetic clinic.
Cockram CS; Pui PC; Keung CC; Moon YS; Swaminathan R
Diabetes Res Clin Pract; 1990 Apr; 9(1):43-8. PubMed ID: 2351039
[TBL] [Abstract][Full Text] [Related]
4. Serial measurement of serum fructosamine and glycosylated haemoglobin as indices of glycaemic control in diabetic pregnancy.
Thai AC; Lui KF; Low EG; Ng WY; Kek LP
Ann Acad Med Singap; 1991 Nov; 20(6):732-5. PubMed ID: 1803958
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
[TBL] [Abstract][Full Text] [Related]
6. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
MacRury SM; Kilpatrick ES; Paterson KR; Dominiczak MH
Clin Chim Acta; 1991 May; 199(1):51-8. PubMed ID: 1934502
[TBL] [Abstract][Full Text] [Related]
7. Serum fructosamine and glycated haemoglobin measurements in diabetic control.
Hindle EJ; Rostron GM; Clark SA; Gatt JA
Arch Dis Child; 1986 Feb; 61(2):113-7. PubMed ID: 3954436
[TBL] [Abstract][Full Text] [Related]
8. Level of serum fructosamine in Saudi diabetic patients.
Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
[TBL] [Abstract][Full Text] [Related]
9. Use of fructosamine and glycated haemoglobin to verify self blood glucose monitoring data in diabetic pregnancy.
Parfitt VJ; Clark JD; Turner GM; Hartog M
Diabet Med; 1993 Mar; 10(2):162-6. PubMed ID: 8458194
[TBL] [Abstract][Full Text] [Related]
10. Long-term performance of the fructosamine assay.
Dominiczak MH; Macrury SM; Orrell JM; Paterson KR
Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():627-33. PubMed ID: 3254102
[TBL] [Abstract][Full Text] [Related]
11. The value of HbA1 and fructosamine in predicting impaired glucose tolerance--an alternative to OGTT to detect diabetes mellitus or gestational diabetes.
Salemans TH; van Dieijen-Visser MP; Brombacher PJ
Ann Clin Biochem; 1987 Sep; 24 ( Pt 5)():447-52. PubMed ID: 3662394
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities.
Guillausseau PJ; Charles MA; Paolaggi F; Timsit J; Chanson P; Peynet J; Godard V; Eschwege E; Rousselet F; Lubetzki J
Diabetes Care; 1990 Aug; 13(8):898-900. PubMed ID: 2209329
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of serum fructosamine and HbA1 as markers for metabolic control in patients with changing insulin regimens.
Steen G; Weber RF
Diabetes Res; 1990 Apr; 13(4):177-82. PubMed ID: 2134209
[TBL] [Abstract][Full Text] [Related]
14. An analysis of glycosylated blood proteins and blood glucose profiles over one year in patients with type 1 diabetes.
Winocour PH; Bhatnagar D; Kalsi P; Hillier VF; Anderson DC
Diabet Med; 1989 Nov; 6(8):709-16. PubMed ID: 2532106
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the real-time use of glycosylated haemoglobin and plasma fructosamine in the diabetic clinic.
Watts GF; Macleod AF; Benn JJ; Slavin BM; Morris RW; Williams CD; Kearney EM; Lowy C; Sönksen PH
Diabet Med; 1991 Jul; 8(6):573-9. PubMed ID: 1832359
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of diabetic control by using hemoglobin A1 and fructosamine.
Sridama V; Hansasuta P; Pasatrat S; Bunnag S
J Med Assoc Thai; 1990 Mar; 73(3):130-5. PubMed ID: 2380644
[TBL] [Abstract][Full Text] [Related]
17. [2,070 simultaneous determinations of blood glucose, glucosylated hemoglobin and fructosamine as index of metabolic control in 519 diabetic patients].
Gómez Reyes D; Gea T; Rojas Hidalgo E
Rev Clin Esp; 1989 Nov; 185(7):354-8. PubMed ID: 2623250
[TBL] [Abstract][Full Text] [Related]
18. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of fructosamine, glycosylated hemoglobin and glucose in patients with type II diabetes].
Tvorogova MG; Zaĭtseva TM; Aronskaia EE; Kozlov SG; Sharipova GKh; Titov VN
Klin Lab Diagn; 1995; (1):10-2. PubMed ID: 7757352
[TBL] [Abstract][Full Text] [Related]
20. The use of plasma fructosamine in the assessment of diabetic control.
Saeed BO; elWali NM; Atabani GS; Elmahdi EM; Mukhtar E
Trop Geogr Med; 1991; 43(1-2):51-4. PubMed ID: 1750129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
